Document is current
Any future updates will be listed below
-
Authors
Mohty, Mohamad https://orcid.org/0000-0002-7264-808X
Blaise, Didier
Peffault de Latour, Régis
Labopin, Myriam https://orcid.org/0000-0003-4514-4748
Bourhis, Jean Henri
Bruno, Benedicte
Ceballos, Patrice
Detrait, Marie
Gandemer, Virginie
Huynh, Anne
Izadifar-Legrand, Faezeh
Jubert, Charlotte
Labussière-Wallet, Hélène
Lebon, Delphine https://orcid.org/0000-0002-4073-1559
Maury, Sébastien
Paillard, Catherine
Pochon, Cécile
Renard, Cecile
Rialland, Fanny https://orcid.org/0000-0002-3136-6270
Schneider, Pascale
Sirvent, Anne
Asubonteng, Kobby
Guindeuil, Gwennaëlle
Yakoub-Agha, Ibrahim https://orcid.org/0000-0003-4524-8782
Dalle, Jean-Hugues
-
Funding
Funding for this research was provided by:
Jazz Pharmaceuticals
- License Information
-
More Information
Article History
Received: 12 October 2022
Revised: 7 December 2022
Accepted: 9 December 2022
First Online: 23 December 2022
Competing interests
: MM: has received honoraria and research funding from Jazz Pharmaceuticals. DB: has received honoraria from Jazz Pharmaceuticals. RPdL: has received honoraria from Jazz Pharmaceuticals. ML: has received honoraria from Jazz Pharmaceuticals. JHB: no competing interests. BB: no competing interests. PC: no competing interests. MD: has received research funding from Jazz Pharmaceuticals. VG: no competing interests. AH: has received honoraria from Jazz Pharmaceuticals. FILeG: no competing interests. CJ: has received honoraria from Jazz Pharmaceuticals. HL-W: no competing interests. DL: no competing interests. SM: no competing interests. C Paillard: no competing interests. C Pochon: no competing interests. CR: has received funding from Jazz Pharmaceuticals. FR: no competing interests. PS: no competing interests. AS: no competing interests. KA: employee of Jazz Pharmaceuticals and holds stock and/or stock options in Jazz Pharmaceuticals. GG: employee of Jazz Pharmaceuticals and holds stock and/or stock options in Jazz Pharmaceuticals. IY-A: has received honoraria from Jazz Pharmaceuticals. J-HD: has received honoraria from Jazz Pharmaceuticals.
: This study was conducted in compliance with the ethical principles defined in the Declaration of Helsinki and according to Good Epidemiological Practice defined by ADELF (Association Des Epidémiologistes de Langue Française—Association of French-language Epidemiologists) and current legislation. Written, informed consent was obtained from the patient or the patient’s legal guardian. Data from deceased patients were included if the patient did not express opposition to the collection of their data while they were alive.
